Look for:

Products

ABBOTT LABORATORIES


ISIN:
US0028241000
WKN:
002824100

2024/03/28 18:44:28
Price
113.43 USD
Difference -0.04% (-0.05)

General attributes

ISINUS0028241000
SymbolABT
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)182,211 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)113.42 USD (100)
Ask (Ask size)113.44 USD (200)
Open113.28 USD
High113.935 USD
Low112.93 USD
Close (prev. day)113.48 USD
VWAP113.359217 USD
Volume (pcs)1,955,775
Trading volume221,695,965.35
Number of trades28,159
Last size129

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ABBOTT LABORATORIESPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/28 18:44:28
Price
113.43 USD
Difference -0.04% (-0.05)

General attributes

ISINUS0028241000
SymbolABT
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)182,211 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)113.42 USD (100)
Ask (Ask size)113.44 USD (200)
Open113.28 USD
High113.935 USD
Low112.93 USD
Close (prev. day)113.48 USD
VWAP113.359217 USD
Volume (pcs)1,955,775
Trading volume221,695,965.35
Number of trades28,159
Last size129

Performance and Risk

6m1Y3Y
Perf (%)+18.79%+15.25%-7.04%
Perf (abs.)+17.95+15.02-8.59
Beta0.330.430.73
Volatility19.0619.5322.56
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)111.41 USD (7,407,396)
Ø price 30 days | Ø volume 30 days (pcs.)116.58 USD (6,121,514)
Ø price 100 days | Ø volume 100 days (pcs.)110.00 USD (5,626,463)
Ø price 250 days | Ø volume 250 days (pcs.)106.40 USD (5,316,921)
YTD High | date121.64 USD (2024/03/08)
YTD Low | date109.11 USD (2024/03/25)
52 Weeks High | date121.64 USD (2024/03/08)
52 Weeks Low | date89.67 USD (2023/10/12)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
BX Swiss2024/03/2818:00101.761 CHF0.001
Berlin2024/03/2818:43105.02 EUR0.0015
Duesseldorf2024/03/2816:31104.60 EUR0.005
Frankfurt2024/03/2817:44104.88 EUR0.034
Hamburg2024/03/2808:10104.48 EUR0.001
Hanover2024/03/2808:10104.48 EUR0.001
London Stock Exchange2024/03/2814:33113.20 USD0.013
Munich2024/03/2808:05104.46 EUR0.001
NYSE2024/03/2818:44113.43 USD221.7028,159
SIX Swiss Exchange2024/02/1917:3193.00 CHF0.001
Stuttgart2024/03/2809:08105.02 EUR0.002
Tradegate2024/03/2817:49104.44 EUR0.2246
Vienna Stock Exchange2024/03/2817:32104.80 EUR0.001
Xetra2024/03/2817:35104.82 EUR0.0420

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2546&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABBOTT LABORATORIES
- -
100 Abbott Park Road - 60064-6400 Abbott Park
Telefon: +1-224-667-6100
Fax: +
E-mail: -

PDF Downloads

Company report: ABBOTT LABORATORIESPDF Download

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Members of Management Board

Robert AlpernMember of Board of Directors
Sally BlountMember of Board of Directors
Claire Babineaux-FontenotMember of Board of Directors
Daniel StarksMember of Board of Directors
Darren McDewMember of Board of Directors
John StrattonMember of Board of Directors
Michael O'GradyMember of Board of Directors
Michael RomanMember of Board of Directors
Michelle KumbierMember of Board of Directors
Nancy McKinstryMember of Board of Directors
Paola GonzalezMember of Board of Directors
Robert B. FordChairman of Managing Board
John M. CapekMember of Executive Committee
Alejandro WellischMember of Executive Committee
Andrea F. WainerMember of Executive Committee
Andrew H. LaneMember of Executive Committee
Christopher J. CalamariMember of Executive Committee
Daniel SalvadoriMember of Executive Committee
Greg AhlbergMember of Executive Committee
Hubert L. AllenMember of Executive Committee
J. Scott HouseMember of Executive Committee
Jared L. WatkinMember of Executive Committee
John F. GinascolMember of Executive Committee
Joseph ManningMember of Executive Committee
Julie TylerMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.